Get startedLog in
    Picture of Onkure Therapeutics logo

    OKUR — Onkure Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    All News

    Brief: Reneo Pharmaceuticals Receives Fast Track Designation From The FDA For Mavodelpar

    Picture of Onkure Therapeutics logoOnkure Therapeutics
    31/01/2023 14:09
    Jan 31 (Reuters) - Reneo Pharmaceuticals Inc  RPHM.O :
    * RENEO PHARMACEUTICALS RECEIVES FAST TRACK DESIGNATION FROM
THE
FDA FOR MAVODELPAR (REN001) IN A GENOTYPE OF LONG-CHAIN FATTY
ACID OXIDATION DISORDER (LC-FAOD)
    * RENEO PHARMACEUTICALS INC - EXPECTS TOPLINE DATA FROM
STRIDE
STUDY IN Q4 OF THIS YEAR

Source text for Eikon:  ID:nGNX3xH2Pk 
Further company coverage:  RPHM.O 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Onkure Therapeutics

    See all news